Nathan, the Co-Founder and Chief Strategy Officer, plays a pivotal role in shaping Proscia’s path forward in the world of digital pathology. With a vision to elevate pathology’s role in achieving precision medicine, Proscia has emerged as a leader in the market, attracting major diagnostic laboratories and 14 of the top 20 pharmaceutical companies as valued customers. Nathan’s expertise lies at the intersection of the company’s customers, products, and the broader digital pathology community. His responsibilities include identifying strategic growth opportunities and spearheading Proscia’s involvement in industry initiatives. Nathan’s educational background encompasses a Bachelor’s Degree in Biomedical Engineering from Johns Hopkins University and a Master’s degree in Biomedical Innovation and Development from the Georgia Institute of Technology. Through his vision and guidance, Proscia continues to drive innovation in life sciences R&D and shape the future of digital pathology.
What led to the rise of digital pathology adoption?
How is digital pathology helping to improve outcomes for cancer patients?
What are some applications of AI in life sciences R&D that are making an impact today?
How is pathology data helping to advance the quest for precision medicine?
How do you envision the future of cancer diagnosis?
Life sciences R&D
Nathan uses a Shure Mv7 and earbuds on every podcast appearance to ensure the quality of the audio